PTAFR and escherichia coli infection: Preliminary experiments suggest that PAFR antagonists would be active in vivo in chickens (data not shown), and a proof of concept on the use of PAFR antagonists to limit exacerbated inflammation associated with experimental colibacillosis are currently being performed.